Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

investorenquiries@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

28 July Appendix 4C and Quarterly Update

200728_Appendix4CandQuarterlyUpdate

Category: News & Announcements 2020By PharmAust July 28, 2020

Related posts

December 31, Top 20 Shareholders
January 4, 2021

December 23, PharmAust Commences MPL Manufacture for Human Clinical Trials
December 23, 2020

December 22, PharmAust Set to Commence Phase IIb Anticancer Canine Trial
December 22, 2020

December 21, Epichem Awarded DNDi Extension
December 21, 2020

December 4, Issued Capital
December 4, 2020

November 30, Top 20 Shareholders
December 1, 2020

Recent Articles

Canine Cancer Trial Update
March 27, 2023
Free Biotech & Nutrition Investor Webinar
March 17, 2023
First Patient of Cohort 2 Dosed in MND Trial 3 market sensitive
February 20, 2023
PharmAust canine trial update 18 market sensitive
February 10, 2023

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust @pharmaust ·

2h

PharmAust completes patient enrolment for MPL trial with sights on US$3.6 billion Motor Neurone Disease market

https://stockhead.com.au/health/pharmaust-completes-patient-enrolment-for-mpl-trial-with-sights-on-us3-6-billion-motor-neurone-disease-market/

Reply on Twitter 1641272193236758529 Retweet on Twitter 1641272193236758529 3 Like on Twitter 1641272193236758529 5 Twitter 1641272193236758529

PharmAust @pharmaust ·

4h

Pandemic Pet Adoptions Propel Rise of a $500 Billion Global Market
Via ⁦@Bloomberg⁩ https://www.bloomberg.com/news/articles/2023-03-24/pet-industry-outlook-is-strong-despite-rising-costs-of-food-vet-care

Reply on Twitter 1641241590726561792 Retweet on Twitter 1641241590726561792 1 Like on Twitter 1641241590726561792 2 Twitter 1641241590726561792

PharmAust @pharmaust ·

6h

MND Trial Completes Enrolment of Cohort 2 and Prepares for Interim Analysis

Reply on Twitter 1641205801892339713 Retweet on Twitter 1641205801892339713 Like on Twitter 1641205801892339713 8 Twitter 1641205801892339713

Load More

Copyright © 2023 PharmAust. All rights reserved.

nil

Website Design & Digital Marketing Perth by Total Click Solutions